Amgen and AstraZeneca today announced that the U.S. Food and Drug Administration (FDA) approved TEZSPIRE® (tezepelumab-ekko) for the add-on maintenance treatment of inadequately controlled chronic ...
Three data center projects did not follow through on the economic promises they made to Virginia, according to an unreleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback